共 283 条
[61]
Mayor A(2013)Curcumin inhibits prostate cancer metastasis Mol. Pharm. 10 2676-1527
[62]
Tardivel A(2007) by targeting the inflammatory cytokines CXCL1 and -2 Adv. Exp. Med. Biol. 595 453-4530
[63]
Tschopp J(2012)Synergistic interaction of paclitaxel and curcumin with cyclodextrin polymer complexation in human cancer cells Cancer Chemother. Pharmacol. 69 679-682
[64]
Mimeault M(2009)Pharmacokinetics and pharmacodynamics of curcumin Eur. J. Pharm. Sci. 37 223-510
[65]
Batra SK(2012)Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice Asian Pac. J. Trop. Biomed. 2 841-1953
[66]
Kristal AR(2011)Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Food Funct. 2 373-2142
[67]
Colli JL(2012)Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles J. Agric. Food Chem. 60 5373-122
[68]
Amling CL(2013)Structure of modified e-polylysine micelles and their application in improving cellular antioxidant activity of curcuminoids Oncol. Rep. 29 1983-453
[69]
Khan N(2011)Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions Int. J. Oncol. 39 1521-473
[70]
Afaq F(2006)Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells Cancer Res. 66 4525-672